Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 22.84 K181.79 K154.14 K152.93 K131.88 K 620.74 K Research & development ————— — Operating income -22.84 K-181.79 K-154.14 K-152.93 K-131.88 K -620.74 K Non-Operating Income, Total —-785.26 K1.17 M1.16 M103.61 K 1.65 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses —-785.26 K1.17 M1.16 M103.61 K 1.65 M Unusual income/expense ————— — Pretax income -22.84 K-967.04 K1.02 M1 M-28.27 K 1.03 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -22.84 K-967.04 K1.02 M1 M-28.27 K 1.03 M Discontinued operations ————— — Net income -22.84 K-967.04 K1.02 M1 M-28.27 K 1.03 M Dilution adjustment —2.92 M—1.03 M1.1 M — Preferred dividends —989.88 K—1.03 M1.05 M — Diluted net income available to common stockholders -22.84 K967.04 K-1.01 M1 M28.27 K 989.36 K Basic earnings per share (Basic EPS) -0.01-0.070.150.060 0.14 Diluted earnings per share (Diluted EPS) -0.01-0.070.150.060 0.14 Average basic shares outstanding 3.33 M3.21 M5.31 M11.5 M11.5 M — Diluted shares outstanding 3.33 M3.21 M5.31 M11.5 M11.5 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —